Episode 06: Interview with Dr. Emma Hapke on MDMA and Psychedelic Assisted Psychotherapy

In this episode, we host Dr. Emma Hapke, psychiatrist, and researcher at University Health Network and the University of Toronto. Dr. Hapke’s work explores MDMA and psychedelic-assisted psychotherapy in people suffering from severe mental health issues like PTSD and treatment-resistant depression. We discuss the latest research, the pros, and cons as well as promoting an upcoming conference on the state of psychedelic research in Canada and worldwide. The conference is happening on 21 Oct 2021. Register here:…ets-170387541724

Episode 05: Interview with Senator and Psychiatrist Stan Kutcher on Mental Health in Canada (Part 2)

In this second part of this interview with Senator Stan Kutcher, we discuss on the social determinants in depression care, the role of policy in enhancing teen mental health, technology and finally, some tips for parents and teens. Read transcript here

Episode 04: Interview with Senator and Psychiatrist Stan Kutcher on Mental Health in Canada (Part 1)

In this episode, Dr. Sagar Parikh interviews Canadian Senator Stan Kutcher on his journey becoming a psychiatrist, getting involved in teen mental health, and discussions on how the school system can take part in providing mental health care. Read transcript here

Episode 03: Nothing About Us Without Us- Community Involvement in Research

In this episode we discuss the importance of the Community Advisory Committee (CAC) at CAN-BIND. We also interview 2 of our CAC members (Madeline and Michael) on their personal experiences. Read transcript here

Episode 02: Ketamine Vs ECT for Treatment Resistant Depression

Most people with treatment-resistant depression are referred for electroconvulsive therapy (ECT). Ketamine is a novel agent found to also be effective. This CAN-BIND study asks the question how effective is ECT versus ketamine? Read transcript here

Episode 01: Neuroplasticity, Depression and Psychedelics

Dr. Gregor Hasler, shares some fascinating new research on neuroplasticity and the use of psychedelics (like LSD) in the treatment of depression. Read transcript here